Literature DB >> 3411339

Localized neuroblastoma treated by surgery: a Pediatric Oncology Group Study.

R Nitschke1, E I Smith, S Shochat, G Altshuler, H Travers, J J Shuster, F A Hayes, R Patterson, N McWilliams.   

Abstract

A prospective study was designed to evaluate the outcome of patients with localized resectable neuroblastoma without regional lymph node involvement when no therapy beyond surgical resection was administered. One hundred one patients observed for 3 to 60 months had a 2-year disease-free survival of 89% (SE = 5%). Of the nine patients experiencing relapse, only three have died. There were no apparent distinguishing characteristics of the nine failures. Due to the favorable prognosis of the subset of neuroblastoma patients, prognostic factor analysis had very limited power and lacked clinical importance. Complete gross removal of the localized tumors is adequate therapy to ensure the survival of the majority of these patients.

Entities:  

Mesh：

Year:  1988        PMID： 3411339     DOI： 10.1200/JCO.1988.6.8.1271

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


  19 in total

1.  Presence of 1q gain and absence of 7p gain are new predictors of local or metastatic relapse in localized resectable neuroblastoma.

Authors:  Annalisa Pezzolo; Elena Rossi; Stefania Gimelli; Federica Parodi; Francesca Negri; Massimo Conte; Angela Pistorio; Angela Sementa; Vito Pistoia; Orsetta Zuffardi; Claudio Gambini
Journal:  Neuro Oncol       Date:  2008-10-15       Impact factor: 12.300

2.  Prognostic importance of DNA flow cytometrical, histopathological and immunohistochemical parameters in neuroblastomas.

Authors:  N L Carlsen; K Ornvold; I J Christensen; H Laursen; J K Larsen
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 3.  Neuroblastoma.

Authors:  S Shah; Y Ravindranath
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

4.  Radiation therapy as part of local control of metastatic neuroblastoma: the St Jude Children's Research Hospital experience.

Authors:  Jared R Robbins; Matthew J Krasin; Atmaram S Pai Panandiker; Amy Watkins; Jianrong Wu; Victor M Santana; Wayne L Furman; Andrew M Davidoff; Lisa M McGregor
Journal:  J Pediatr Surg       Date:  2010-04       Impact factor: 2.545

5.  Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.

Authors:  E K Pivnick; W L Furman; G V Velagaleti; J J Jenkins; N A Chase; R C Ribeiro
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

6.  Neuroblastoma resection in an adult with a 10-year history of chest-mass shadow.

Authors:  R Yamamoto; H Tada; A Kishi; T Tojo; H Asada; T Inoue
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2000-12

7.  Intensive chemotherapy in children with stage IV neuroblastoma.

Authors:  P Kusumakumari; T V Ajithkumar; S Hariharan; R R Varma; V G Chellam; R Nair; M K Nair
Journal:  Indian J Pediatr       Date:  1999 Nov-Dec       Impact factor: 1.967

8.  A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.

Authors:  Jed G Nuchtern; Wendy B London; Carol E Barnewolt; Arlene Naranjo; Patrick W McGrady; James D Geiger; Lisa Diller; Mary Lou Schmidt; John M Maris; Susan L Cohn; Robert C Shamberger
Journal:  Ann Surg       Date:  2012-10       Impact factor: 12.969

Review 9.  Neuroblastoma.

Authors:  T Humpl
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

10.  Complete surgical resection combined with aggressive adjuvant chemotherapy and bone marrow transplantation prolongs survival in children with advanced neuroblastoma.

Authors:  R S Chamberlain; R Quinones; P Dinndorf; N Movassaghi; M Goodstein; K Newman
Journal:  Ann Surg Oncol       Date:  1995-03       Impact factor: 5.344
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.